Modafinil: A Review of Neurochemical Actions and Effects on Cognition

[1]  S. Westmoreland,et al.  Rhesus Monkey Trace Amine-Associated Receptor 1 Signaling: Enhancement by Monoamine Transporters and Attenuation by the D2 Autoreceptor in Vitro , 2007, Journal of Pharmacology and Experimental Therapeutics.

[2]  G. Miller,et al.  Trace Amine-Associated Receptor 1 Is a Modulator of the Dopamine Transporter , 2007, Journal of Pharmacology and Experimental Therapeutics.

[3]  M. Dopheide,et al.  Modafinil improves attention, inhibitory control, and reaction time in healthy, middle-aged rats , 2007, Pharmacology Biochemistry and Behavior.

[4]  M. Hirshkowitz,et al.  Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome. , 2007, Respiratory medicine.

[5]  Trevor W. Robbins,et al.  Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol , 2007, Psychopharmacology.

[6]  H. Haas,et al.  Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors , 2007, Neuropharmacology.

[7]  R. Shelton,et al.  A Randomized, Double-Blind, Crossover Trial of Modafinil on Mood , 2007, Journal of clinical psychopharmacology.

[8]  P. Deyn,et al.  P300 and treatment effect of modafinil on fatigue in multiple sclerosis , 2007, Journal of Clinical Neuroscience.

[9]  R. Drucker-Colín,et al.  Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats , 2007, Behavioural Brain Research.

[10]  H. Semlitsch,et al.  Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy , 2007, Psychiatry Research: Neuroimaging.

[11]  Sean A Spence,et al.  Impact of modafinil on prefrontal executive function in schizophrenia. , 2006, The American journal of psychiatry.

[12]  I. Anghelescu,et al.  Manic switch in a patient with treatment-resistant bipolar depression treated with modafinil. , 2006, The Journal of clinical psychiatry.

[13]  R. Thomas,et al.  Modafinil activates cortical and subcortical sites in the sleep-deprived state. , 2006, Sleep.

[14]  T. Spencer,et al.  Modafinil Occupies Dopamine and Norepinephrine Transporters in Vivo and Modulates the Transporters and Trace Amine Activity in Vitro , 2006, Journal of Pharmacology and Experimental Therapeutics.

[15]  D. Bozyczko‐Coyne,et al.  Armodafinil, the R-enantiomer of modafinil: Wake-promoting effects and pharmacokinetic profile in the rat , 2006, Pharmacology Biochemistry and Behavior.

[16]  T. Farrow,et al.  Modafinil and unconstrained motor activity in schizophrenia: double-blind crossover placebo-controlled trial. , 2006, The British journal of psychiatry : the journal of mental science.

[17]  C. Bradshaw,et al.  Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers , 2006, Journal of psychopharmacology.

[18]  S. Vosburg,et al.  Modafinil Attenuates Disruptions in Cognitive Performance During Simulated Night-Shift Work , 2006, Neuropsychopharmacology.

[19]  Nancy J Wesensten,et al.  Effects of modafinil on cognitive performance and alertness during sleep deprivation. , 2006, Current pharmaceutical design.

[20]  J. Swanson,et al.  A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study. , 2006, The Journal of clinical psychiatry.

[21]  J. Swanson,et al.  A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

[22]  D. White,et al.  Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. , 2006, Clinical therapeutics.

[23]  G. Williams,et al.  Under the curve: Critical issues for elucidating D1 receptor function in working memory , 2006, Neuroscience.

[24]  J. Ballon,et al.  A systematic review of modafinil: Potential clinical uses and mechanisms of action. , 2006, The Journal of clinical psychiatry.

[25]  J. Harsh,et al.  The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy* , 2006, Current medical research and opinion.

[26]  M. Fava,et al.  Modafinil Augmentation of SSRI Therapy in Patients with Major Depressive Disorder and Excessive Sleepiness and Fatigue: A 12-Week, Open-label, Extension Study , 2006, CNS Spectrums.

[27]  P. Haerich,et al.  Cognitive performance following modafinil versus placebo in sleep-deprived emergency physicians: a double-blind randomized crossover study. , 2006, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[28]  F. Chauveau,et al.  Modafinil-induced modulation of working memory and plasma corticosterone in chronically-stressed mice , 2006, Pharmacology Biochemistry and Behavior.

[29]  J. Swanson,et al.  Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation. , 2006, The Journal of clinical psychiatry.

[30]  J. Doljansky,et al.  Cognitive Performance during Sustained Wakefulness: A Low Dose of Caffeine Is Equally Effective as Modafinil in Alleviating the Nocturnal Decline , 2006, Chronobiology international.

[31]  D. Dinges,et al.  Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss* , 2006, Current medical research and opinion.

[32]  R. Woolson,et al.  Modafinil and Cocaine Interactions , 2006, The American journal of drug and alcohol abuse.

[33]  J. Wisor,et al.  Dopaminergic—adrenergic interactions in the wake promoting mechanism of modafinil , 2005, Neuroscience.

[34]  Jon T. Willie,et al.  Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates , 2005, Neuroscience.

[35]  J. Swanson,et al.  Efficacy and Safety of Modafinil Film–Coated Tablets in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study , 2005, Pediatrics.

[36]  P. Chandra,et al.  Modafinil-induced irritability and aggression? A report of 2 bipolar patients. , 2005, Journal of clinical psychopharmacology.

[37]  V. Uralets,et al.  Detection of modafinil in human urine by gas chromatography-mass spectrometry. , 2005, Journal of pharmaceutical and biomedical analysis.

[38]  N. Oskooilar.  A case of premature ventricular contractions with modafinil. , 2005, The American journal of psychiatry.

[39]  S. File,et al.  Cognitive effects of modafinil in student volunteers may depend on IQ , 2005, Pharmacology Biochemistry and Behavior.

[40]  T. Balkin,et al.  Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation , 2005, Journal of sleep research.

[41]  D. Dinges,et al.  Modafinil for excessive sleepiness associated with shift-work sleep disorder. , 2005, The New England journal of medicine.

[42]  Jonathan D. Cohen,et al.  An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. , 2005, Annual review of neuroscience.

[43]  Jose Alvir,et al.  Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications. , 2005, The Journal of clinical psychiatry.

[44]  I. Wilkinson,et al.  Modafinil modulates anterior cingulate function in chronic schizophrenia. , 2005, The British journal of psychiatry : the journal of mental science.

[45]  C. Bradshaw,et al.  Does modafinil activate the locus coeruleus in man? Comparison of modafinil and clonidine on arousal and autonomic functions in human volunteers , 2005, Psychopharmacology.

[46]  Hong Yang,et al.  Primate Trace Amine Receptor 1 Modulation by the Dopamine Transporter , 2005, Journal of Pharmacology and Experimental Therapeutics.

[47]  S. File,et al.  Does Modafinil Enhance Cognitive Performance in Young Volunteers Who Are Not Sleep-Deprived? , 2005, Journal of clinical psychopharmacology.

[48]  D. Cohen,et al.  Mania in a boy treated with modafinil for narcolepsy. , 2005, The American journal of psychiatry.

[49]  K. Fuxe,et al.  Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: A dual probe microdialysis study in awake rat , 2005, Synapse.

[50]  H. Schwertner,et al.  Determination of modafinil in plasma and urine by reversed phase high-performance liquid-chromatography. , 2005, Journal of pharmaceutical and biomedical analysis.

[51]  G. Dawson,et al.  Assessment of modafinil on attentional processes in a five-choice serial reaction time test in the rat , 2005, Journal of psychopharmacology.

[52]  M. Fava,et al.  A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. , 2005, The Journal of clinical psychiatry.

[53]  G. Gessa,et al.  Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex , 2005, Journal of neurochemistry.

[54]  B. Saletu,et al.  EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil , 2004, Journal of Neurology.

[55]  J. Seamans,et al.  The principal features and mechanisms of dopamine modulation in the prefrontal cortex , 2004, Progress in Neurobiology.

[56]  S. Thomas,et al.  Potency of catecholamines and other l-tyrosine derivatives at the cloned mouse adrenergic receptors , 2004, Neuropharmacology.

[57]  J. G. McCoy,et al.  Modafinil facilitates performance on a delayed nonmatching to position swim task in rats , 2004, Pharmacology Biochemistry and Behavior.

[58]  Luke Clark,et al.  Modafinil Improves Cognition and Attentional Set Shifting in Patients with Chronic Schizophrenia , 2004, Neuropsychopharmacology.

[59]  J. Baranski,et al.  Effects of modafinil on cognitive and meta‐cognitive performance , 2004, Human psychopharmacology.

[60]  U. Müller,et al.  Effects of modafinil on working memory processes in humans , 2004, Psychopharmacology.

[61]  A. Arnsten.  Adrenergic targets for the treatment of cognitive deficits in schizophrenia , 2004, Psychopharmacology.

[62]  Danielle C. Turner,et al.  Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder , 2004, Biological Psychiatry.

[63]  G. Bernardi,et al.  Inhibitory effects of trace amines on rat midbrain dopaminergic neurons , 2004, Neuropharmacology.

[64]  J. Walsh,et al.  Modafinil improves alertness, vigilance, and executive function during simulated night shifts. , 2004, Sleep.

[65]  Patricia S. Goldman-Rakic,et al.  Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction , 2004, Psychopharmacology.

[66]  D. Restuccia,et al.  Influence of modafinil on somatosensory input processing in the human brain-stem , 2004, Clinical Neurophysiology.

[67]  H. Myrick,et al.  Modafinil: preclinical, clinical, and post-marketing surveillance--a review of abuse liability issues. , 2004, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[68]  G. Gessa,et al.  Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex. , 2004, European journal of pharmacology.

[69]  R. Hughes,et al.  Effects of Modafinil on Wakefulness and Executive Function in Patients With Narcolepsy Experiencing Late-Day Sleepiness , 2004, Clinical neuropharmacology.

[70]  S. File,et al.  The cognitive-enhancing properties of modafinil are limited in non-sleep-deprived middle-aged volunteers , 2004, Pharmacology Biochemistry and Behavior.

[71]  H. Solvason,et al.  A Prospective Trial of Modafinil as an Adjunctive Treatment of Major Depression , 2004, Journal of clinical psychopharmacology.

[72]  P. Luppi,et al.  Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study. , 2004, Sleep.

[73]  G. Gessa,et al.  Alpha2‐adrenoceptor mediated co‐release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex , 2004, Journal of neurochemistry.

[74]  M. Hirshkowitz,et al.  Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study. , 2003, Chest.

[75]  A. Célérier,et al.  Enhancement of learning processes following an acute modafinil injection in mice , 2003, Pharmacology Biochemistry and Behavior.

[76]  Sylvain Crochet,et al.  Dopaminergic modulation of behavioral states in mesopontine tegmentum: a reverse microdialysis study in freely moving cats. , 2003, Sleep.

[77]  T. Rugino,et al.  Modafinil in children with attention-deficit hyperactivity disorder. , 2003, Pediatric neurology.

[78]  S. Nishino.  The hypocretin/orexin system in health and disease , 2003, Biological Psychiatry.

[79]  S. File,et al.  Modafinil affects mood, but not cognitive function, in healthy young volunteers , 2003, Human psychopharmacology.

[80]  A. Yamatodani,et al.  Modafinil increases histamine release in the anterior hypothalamus of rats , 2003, Neuroscience Letters.

[81]  M. Rosenthal,et al.  Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia , 2003, Schizophrenia Research.

[82]  G. Gessa,et al.  Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic , 2003, Psychopharmacology.

[83]  H. Haas,et al.  The role of histamine and the tuberomamillary nucleus in the nervous system , 2003, Nature Reviews Neuroscience.

[84]  R. Pigeau,et al.  Distinctive effects of modafinil and d-amphetamine on the homeostatic and circadian modulation of the human waking EEG , 2003, Psychopharmacology.

[85]  M. Tarnopolsky,et al.  Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy , 2002, Neurology.

[86]  D. Quartermain,et al.  Role of brain α1B‐adrenoceptors in modafinil‐induced behavioral activity , 2002, Synapse.

[87]  D. Quartermain,et al.  Stress-induced subsensitivity to modafinil and its prevention by corticosteroids , 2002, Pharmacology Biochemistry and Behavior.

[88]  J. Balthazart,et al.  Dopamine Activates Noradrenergic Receptors in the Preoptic Area , 2002, The Journal of Neuroscience.

[89]  A. Célérier,et al.  Improvement of learning processes following chronic systemic administration of modafinil in mice , 2002, Pharmacology Biochemistry and Behavior.

[90]  C. D. Frith,et al.  The Role of the Dorsolateral Prefrontal Cortex: Evidence from the Effects of Contextual Constraint in a Sentence Completion Task , 2002, NeuroImage.

[91]  J. Dequardo.  Modafinil-associated clozapine toxicity. , 2002, The American journal of psychiatry.

[92]  M. Rupp,et al.  Modafinil in treatment of fatigue in multiple sclerosis , 2002, Journal of Neurology.

[93]  Daniel Durstewitz,et al.  The computational role of dopamine D1 receptors in working memory , 2002, Neural Networks.

[94]  S. Arora,et al.  Steady‐State Pharmacokinetics and Tolerability of Modafinil Administered Alone or in Combination with Dextroamphetamine in Healthy Volunteers , 2002, Journal of clinical pharmacology.

[95]  K. Fuxe,et al.  Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rat by modafinil: Possible relevance for wakefulness and depression , 2002, Journal of neuroscience research.

[96]  R. Narendran,et al.  Is psychosis exacerbated by modafinil? , 2002, Archives of general psychiatry.

[97]  A. Beck‐Sickinger,et al.  The SK-N-MC cell line expresses an orexin binding site different from recombinant orexin 1-type receptor. , 2002, European journal of biochemistry.

[98]  S. Arora,et al.  Effect of Modafinil at Steady State on the Single‐Dose Pharmacokinetic Profile of Warfarin in Healthy Volunteers , 2002, Journal of clinical pharmacology.

[99]  R. Wise,et al.  Dopamine Uptake through the Norepinephrine Transporter in Brain Regions with Low Levels of the Dopamine Transporter: Evidence from Knock-Out Mouse Lines , 2002, The Journal of Neuroscience.

[100]  S. Arora,et al.  Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers , 2002, Clinical pharmacology and therapeutics.

[101]  S. Nicolaidis,et al.  Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats , 2001, Neuroreport.

[102]  G. Flore,et al.  Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex , 2001, Molecular Psychiatry.

[103]  S. Arora,et al.  Steady‐State Pharmacokinetics and Tolerability of Modafinil Given Alone or in Combination with Methylphenidate in Healthy Volunteers , 2001, Journal of clinical pharmacology.

[104]  B. Westerink,et al.  The noradrenaline-dopamine interaction in the rat medial prefrontal cortex studied by multi-probe microdialysis. , 2001, European journal of pharmacology.

[105]  K. Fuxe,et al.  Modafinil does not affect serotonin efflux from rat frontal cortex synaptosomes: comparison with known serotonergic drugs , 2001, Brain Research.

[106]  I. Sora,et al.  Dopaminergic Role in Stimulant-Induced Wakefulness , 2001, The Journal of Neuroscience.

[107]  A. Célérier,et al.  First evidence of a delay-dependent working memory-enhancing effect of modafinil in mice , 2001, Neuroreport.

[108]  T. Rugino,et al.  Effects of modafinil in children with attention-deficit/hyperactivity disorder: an open-label study. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[109]  P. Goldman-Rakic,et al.  Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[110]  C. Piérard,et al.  Effect of modafinil on cerebral blood flow of anaesthetised rats , 2000, Experimental Brain Research.

[111]  C. Saper,et al.  Hypothalamic Arousal Regions Are Activated during Modafinil-Induced Wakefulness , 2000, The Journal of Neuroscience.

[112]  K. Fuxe,et al.  Amplification of cortical serotonin release: a further neurochemical action of the vigilance-promoting drug modafinil , 2000, Neuropharmacology.

[113]  P. Luppi,et al.  Single‐unit and polygraphic recordings associated with systemic or local pharmacology: A multi‐purpose stereotaxic approach for the awake, anaesthetic‐free, and head‐restrained rat , 2000, Journal of neuroscience research.

[114]  C. Guilleminault,et al.  Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy. , 2000, Sleep medicine.

[115]  P. Robertson,et al.  In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[116]  D. Mayleben,et al.  Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy , 2000, Neurology.

[117]  M. Aldrich,et al.  Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy , 2000 .

[118]  M. Jouvet,et al.  Effects of amphetamine and modafinil on the sleep/wake cycle during experimental hypersomnia induced by sleep deprivation in the cat , 2000, Journal of sleep research.

[119]  M. Millan,et al.  Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents , 2000, Journal of psychopharmacology.

[120]  P. Blandina,et al.  Central histaminergic system and cognition , 2000, Neuroscience & Biobehavioral Reviews.

[121]  D. Jasinski.  An evaluation of the abuse potential of modafinil using methylphenidate as a reference , 2000, Journal of psychopharmacology.

[122]  K. Fuxe,et al.  A stereological study on the neuroprotective actions of acute Modafinil treatment on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigral lesions of the male black mouse , 1999, Neuroscience Letters.

[123]  Bao-Ming Li,et al.  Alpha-2 Adrenergic Modulation of Prefrontal Cortical Neuronal Activity Related to Spatial Working Memory in Monkeys , 1999, Neuropsychopharmacology.

[124]  Jonathan D. Cohen,et al.  Cognition and control in schizophrenia: a computational model of dopamine and prefrontal function , 1999, Biological Psychiatry.

[125]  Jon T. Willie,et al.  Narcolepsy in orexin Knockout Mice Molecular Genetics of Sleep Regulation , 1999, Cell.

[126]  Donald C. Cooper,et al.  Loss of autoreceptor functions in mice lacking the dopamine transporter , 1999, Nature Neuroscience.

[127]  S. Haber,et al.  Immunocytochemical localization of the dopamine transporter in human brain , 1999, The Journal of comparative neurology.

[128]  R. Sangal,et al.  Visual P300 latency predicts treatment response to modafinil in patients with narcolepsy , 1999, Clinical Neurophysiology.

[129]  E. Bullmore,et al.  Functional magnetic resonance imaging neuroactivation studies in normal subjects and subjects with the narcoleptic syndrome. Actions of modafinil , 1999, Journal of sleep research.

[130]  K. Fuxe,et al.  The Vigilance Promoting Drug Modafinil Increases Extracellular Glutamate Levels in the Medial Preoptic Area and the Posterior Hypothalamus of the Conscious Rat: Prevention by Local GABAA Receptor Blockade , 1999, Neuropsychopharmacology.

[131]  Y. Wong,et al.  Open‐Label, Single‐Dose Pharmacokinetic Study of Modafinil Tablets: Influence of Age and Gender in Normal Subjects , 1999, Journal of clinical pharmacology.

[132]  G. Aghajanian,et al.  5-HT2A receptor or alpha1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. , 1999, European journal of pharmacology.

[133]  J. Cohen,et al.  The role of locus coeruleus in the regulation of cognitive performance. , 1999, Science.

[134]  K. Fuxe,et al.  Effects of the vigilance promoting drug modafinil on the synthesis of GABA and glutamate in slices of rat hypothalamus , 1999, Neuroscience Letters.

[135]  Y. Wong,et al.  A Double‐Blind, Placebo‐Controlled, Ascending‐Dose Evaluation of the Pharmacokinetics and Tolerability of Modafinil Tablets in Healthy Male Volunteers , 1999, Journal of clinical pharmacology.

[136]  R B Sangal,et al.  Longer Auditory and Visual P300 Latencies in Patients with Narcolepsy , 1999, Clinical EEG.

[137]  K. Fuxe,et al.  Modafinil prevents glutamate cytotoxicity in cultured cortical neurons , 1998, Neuroreport.

[138]  P. Goldman-Rakic,et al.  D1 Receptor in Interneurons of Macaque Prefrontal Cortex: Distribution and Subcellular Localization , 1998, The Journal of Neuroscience.

[139]  Y. Wong,et al.  Comparison of the Single‐Dose Pharmacokinetics and Tolerability of Modafinil and Dextroamphetamine Administered Alone or in Combination in Healthy Male Volunteers , 1998, Journal of clinical pharmacology.

[140]  T. Sawaguchi.  Attenuation of delay-period activity of monkey prefrontal neurons by an alpha2-adrenergic antagonist during an oculomotor delayed-response task. , 1998, Journal of neurophysiology.

[141]  K. Fuxe,et al.  The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission , 1998, Neuroscience Letters.

[142]  P. Contreras,et al.  Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine , 1998, Neuroscience.

[143]  C. Aoki,et al.  Cellular and subcellular sites for noradrenergic action in the monkey dorsolateral prefrontal cortex as revealed by the immunocytochemical localization of noradrenergic receptors and axons. , 1998, Cerebral cortex.

[144]  Y. Wong,et al.  Single‐Dose Pharmacokinetics of Modafinil and Methylphenidate Given Alone or in Combination in Healthy Male Volunteers , 1998, Journal of clinical pharmacology.

[145]  P. Contreras,et al.  Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil , 1998, Neuroscience Letters.

[146]  D. Fry,et al.  Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy , 1998, Annals of neurology.

[147]  K. Fuxe,et al.  Modafinil: An antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers , 1997, Biological Psychiatry.

[148]  D. Edgar,et al.  Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat. , 1997, The Journal of pharmacology and experimental therapeutics.

[149]  K. Fuxe,et al.  The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus , 1997, Neuroreport.

[150]  H. Moldofsky,et al.  Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy , 1997, Neurology.

[151]  G. Aston-Jones,et al.  Conditioned responses of monkey locus coeruleus neurons anticipate acquisition of discriminative behavior in a vigilance task , 1997, Neuroscience.

[152]  C. Frith,et al.  The functional anatomy of verbal initiation and suppression using the Hayling Test , 1997, Neuropsychologia.

[153]  A. Besset,et al.  Use of modafinil in the treatment of narcolepsy: A long term follow-up study , 1996, Neurophysiologie Clinique/Clinical Neurophysiology.

[154]  K. Fuxe,et al.  The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor , 1996, Neuroscience Letters.

[155]  M. Jouvet,et al.  Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[156]  L. Gold,et al.  Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil , 1996, Psychopharmacology.

[157]  T. Robbins,et al.  Dissociation in prefrontal cortex of affective and attentional shifts , 1996, Nature.

[158]  J. Costentin,et al.  Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice , 1995, European Neuropsychopharmacology.

[159]  E. Mignot,et al.  Comparative effects of modafinil and amphetamine on daytime sleepiness and cataplexy of narcoleptic dogs. , 1995, Sleep.

[160]  J. Baranski,et al.  Modafinil, d‐amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature , 1995, Journal of sleep research.

[161]  C. Piérard,et al.  Effects of a vigilance-enhancing drug, modafinil, on rat brain metabolism: 2D COSY 1H-NMR study , 1995, Brain Research.

[162]  J. Hieble,et al.  Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification. , 1995, Journal of medicinal chemistry.

[163]  M. Jouvet,et al.  Awakening properties of modafinil without paradoxical sleep rebound: comparative study with amphetamine in the rat , 1995, Neuroscience Letters.

[164]  D. Béracochéa,et al.  Effects of mammillary bodies and mediodorsal thalamic lesions on the acquisition and retention of a learning set in mice: paradoxical effect of the intersession interval , 1995, Behavioural Brain Research.

[165]  K. Fuxe,et al.  Modafinil and cortical γ-aminobutyric acid outflow. Modulation by 5-hydroxytryptamine neurotoxins , 1995 .

[166]  A. Besset,et al.  Modafinil: a double-blind multicentric study. , 1994, Sleep.

[167]  M. Jouvet,et al.  Effects of modafinil-induced wakefulness on glutamine synthetase regulation in the rat brain. , 1994, Brain research. Molecular brain research.

[168]  C. Guilleminault,et al.  Modafinil binds to the dopamine uptake carrier site with low affinity. , 1994, Sleep.

[169]  C. Aoki,et al.  Perikaryal and synaptic localization ofα 2A-adrenergic receptor-like immunoreactivity , 1994, Brain Research.

[170]  G. Aston-Jones,et al.  Locus coeruleus neurons in monkey are selectively activated by attended cues in a vigilance task , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[171]  P S Goldman-Rakic,et al.  D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[172]  F. Rambert,et al.  Lack of pre-synaptic dopaminergic involvement in modafinil activity in anaesthetized mice: In vivo voltammetry studies , 1994, Neuropharmacology.

[173]  J. Costentin,et al.  The stimulant effect of modafinil on wakefulness is not associated with an increase in anxiety in mice , 1994, Psychopharmacology.

[174]  K. Fuxe,et al.  6-Hydroxy-dopamine treatment counteracts the reduction of cortical GABA release produced by the vigilance promoting drug modafinil in the awake freely moving guinea-pig , 1994, Neuroscience Letters.

[175]  P. Goldman-Rakic,et al.  The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. , 1994, Journal of neurophysiology.

[176]  A. Arnsten,et al.  Postsynaptic alpha-2 receptor stimulation improves memory in aged monkeys: Indirect effects of yohimbine versus direct effects of clonidine , 1993, Neurobiology of Aging.

[177]  J. Cai,et al.  Reserpine impairs spatial working memory performance in monkeys: reversal by the α2-adrenergic agonist clonidine , 1993, Brain Research.

[178]  P. Goldman-Rakic,et al.  Characterization of the dopaminergic innervation of the primate frontal cortex using a dopamine-specific antibody. , 1993, Cerebral cortex.

[179]  P. Goldman-Rakic,et al.  Heterogeneous targets of dopamine synapses in monkey prefrontal cortex demonstrated by serial section electron microscopy: a laminar analysis using the silver-enhanced diaminobenzidine sulfide (SEDS) immunolabeling technique. , 1993, Cerebral cortex.

[180]  C. Guilleminault,et al.  Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsy. , 1993, The Journal of pharmacology and experimental therapeutics.

[181]  M. Jouvet,et al.  Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat , 1992, Brain Research.

[182]  K. Fuxe,et al.  Inhibitory effects of the psychoactive drug modafinil on γ-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea-pig , 1992, Naunyn-Schmiedeberg's Archives of Pharmacology.

[183]  M. Meunier,et al.  Differential involvement of anterior and posterior cingulate cortices in spatial discriminative learning in a T-maze in mice , 1991, Behavioural Brain Research.

[184]  P. Goldman-Rakic,et al.  D1 dopamine receptors in prefrontal cortex: involvement in working memory , 1991, Science.

[185]  M. Jouvet,et al.  Effect of modafinil and amphetamine on the rat catecholaminergic neuron activity , 1991, Neuroscience Letters.

[186]  G. Chiara,et al.  Blockade of the Noradrenaline Carrier Increases Extracellular Dopamine Concentrations in the Prefrontal Cortex: Evidence that Dopamine Is Taken up In Vivo by Noradrenergic Terminals , 1990, Journal of neurochemistry.

[187]  F. Rambert,et al.  Modafinil-, amphetamine- and methylphenidate-induced hyperactivities in mice involve different mechanisms , 1990 .

[188]  F. Rambert,et al.  Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals. , 1990, European journal of pharmacology.

[189]  J. Morrison,et al.  Noradrenergic innervation of monkey prefrontal cortex: A dopamine‐β‐hydroxylase immunohistochemical study , 1989, The Journal of comparative neurology.

[190]  J. Beatty,et al.  Contrasting effects of response uncertainty on the task-evoked pupillary response and reaction time. , 1987, Psychophysiology.

[191]  R. Nicoll,et al.  Dopamine decreases the calcium-activated afterhyperpolarization in hippocampal CA1 pyramidal cells , 1986, Brain Research.

[192]  P. Goldman-Rakic,et al.  Alpha 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. , 1985, Science.

[193]  J. Beatty,et al.  Phasic not tonic pupillary responses vary with auditory vigilance performance. , 1982, Psychophysiology.

[194]  J. Beatty.  Task-evoked pupillary responses, processing load, and the structure of processing resources. , 1982, Psychological bulletin.

[195]  F. Bloom,et al.  Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle , 1981, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[196]  F. Rambert,et al.  A possibe alpha-adrenergic mechanism for drug (CRL 40028)-induced hyperactivity. , 1979, European journal of pharmacology.

[197]  J. Glowinski,et al.  Topographical distribution of dopaminergic innervation and dopaminergic receptors of the anterior cerebral cortex of the rat , 1978, Brain Research.

[198]  B. Bunney,et al.  Dopamine and norepinephrine innervated cells in the rat prefrontal cortex: pharmacological differentiation using microiontophoretic techniques. , 1976, Life sciences.

[199]  F. Rambert,et al.  Awakening properties of modafinil: effect on nocturnal activity in monkeys(Macaca mulatta) after acute and repeated administration , 2005, Psychopharmacology.

[200]  C. Guilleminault,et al.  Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancers , 2005, Psychopharmacology.

[201]  A. Arnsten,et al.  Alpha-2 adrenergic agonists decrease distractibility in aged monkeys performing the delayed response task , 2005, Psychopharmacology.

[202]  K. Lynch,et al.  A Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence , 2005, Neuropsychopharmacology.

[203]  K. Fuxe,et al.  Evidence for a protective action of the vigilance promoting drug Modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis , 2005, Experimental Brain Research.

[204]  P. Blandina,et al.  Acetylcholine, histamine, and cognition: two sides of the same coin. , 2004, Learning & memory.

[205]  E. Hellriegel,et al.  Clinical Pharmacokinetic Profile of Modafinil , 2003, Clinical pharmacokinetics.

[206]  Prof. Dr. W. Wolfgang Fleischhacker,et al.  Neuropsychopharmacology , 2003, Journal of Neural Transmission. Supplementa.

[207]  Danielle C. Turner,et al.  Cognitive enhancing effects of modafinil in healthy volunteers , 2002, Psychopharmacology.

[208]  E. Neidhart,et al.  Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil , 2002, The Pharmacogenomics Journal.

[209]  T. Balkin,et al.  Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine , 2001, Psychopharmacology.

[210]  J. Russo,et al.  Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. , 2000, Journal of child and adolescent psychopharmacology.

[211]  S. Sesack,et al.  Cellular and subcellular localization of the dopamine transporter in rat cortex. , 1998, Advances in pharmacology.

[212]  G. Aston-Jones,et al.  Neuromodulation and cognitive performance: recent studies of noradrenergic locus ceruleus neurons in behaving monkeys. , 1998, Advances in pharmacology.

[213]  N. Risch,et al.  HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. US Modafinil in Narcolepsy Multicenter Study Group. , 1998, Tissue antigens.

[214]  G. Aston-Jones,et al.  Role of the locus coeruleus in emotional activation. , 1996, Progress in brain research.

[215]  M. Jouvet,et al.  ネコ脳のアンフェタミン,メチルフェニデート,モダフィニルの覚醒作用における標的ニューロンのc‐fos免疫組織化学による検索 , 1996 .

[216]  K. Fuxe,et al.  Modafinil and cortical gamma-aminobutyric acid outflow. Modulation by 5-hydroxytryptamine neurotoxins. , 1995, European journal of pharmacology.

[217]  C. Aoki,et al.  Perikaryal and synaptic localization of alpha 2A-adrenergic receptor-like immunoreactivity. , 1994, Brain research.